App Store
Google Play
View your reports and upcoming health checkups at one place.
Upload Prescription
Not sure which tests to take? Share your prescription with us and our team will call you.
Mumbai
Chennai
Pune
Bengaluru
Surat
Delhi
Publications
Our publications highlight evidence-based research and pioneering diagnostic methods that are shaping the future of healthcare for women and children.
Most Recent
Neoplastic lesions of Gall bladder including ICPN, an observational study from North East India
Gallbladder cancer can be highly aggressive , and precursor lesions such as Intracholecystic Papillary Neoplasm (ICPN) are increasingly recognized for their malignant potential. In this prospective study from Northeast India the authors conclude that ICPN, though uncommon, carries a significant risk of malignant transformation and must be carefully evaluated to enable early detection and improved clinical outcomes.
Trapped in the Vasculature: Delving into Intravascular B-Cell Lymphoma
IVLBCL remains a diagnostic challenge due to its rarity, nonspecific presentation, and absence of lymphadenopathy. Comprehensive evaluation through peripheral smear, flow cytometry, and immunohistochemistry enabled accurate identification and guided timely treatment—improving patient prognosis.
Myeloid sarcomas of the genitourinary tract: A multi-institutional study of sixteen tumors with review of literature
This multi-institutional study describes Myeloid sarcoma (MS) involving the genitourinary (GU) tract. All tumors were confirmed via clinicopathologic, immunophenotypic, and flow‑cytometric analysis. The series highlights the rare but diverse anatomic presentation of GU‑MS (e.g., kidney, bladder, prostate), underscoring diagnostic challenges due to variable morphology and overlap with other malignancies. The authors emphasize careful immunophenotypic workup and clinical correlation for accurate diagnosis
An Unusual Presentation of IgM Myeloma
This case highlights a rare IgM myeloma presenting with the “5 Cs” of IgM paraproteinemia—cryoglobulinemia, coagulopathy, cold AIHA, clot, and cloudy vision—mimicking Waldenström’s macroglobulinemia. It highlights the clinical need to consider IgM myeloma as a key differential diagnosis, as timely distinction directly influences treatment decisions and patient outcomes.
Molecular analysis for EGFR, ALK, and ROS1 alterations in over 3000 Indian patients with non-small-cell lung cancer: A retrospective observational study
The study retrospectively evaluated more than 3,000 Indian patients with non–small‑cell lung cancer (NSCLC), analyzing alterations in EGFR, ALK and ROS1. The investigators found a substantial prevalence of EGFR mutations, ALK rearrangements and ROS1 rearrangements, underscoring the utility of routine molecular testing in this population.Their results support personalized therapy for Indian NSCLC patients by identifying actionable alterations with potential to guide targeted treatments.
Immunohistochemical studies and molecular classification for the diagnosis and management of breast cancer malignancies An Indian Laboratory perspective
The study classified breast cancer subtypes in patients using immunohistochemistry (IHC). It analyzed tumor samples to categorize cancers into molecular subtypes (based on hormone receptors, HER2 status, etc.), and described their distribution in the studied population. By correlating IHC profiles with clinical/pathological features, the study highlighted subtype prevalence and potential prognostic or therapeutic implications.
Immunohistochemical studies and molecular classification for the diagnosis and management of breast cancer malignancies An Indian Laboratory perspective
The study classified breast cancer subtypes in patients using immunohistochemistry (IHC). It analyzed tumor samples to categorize cancers into molecular subtypes (based on hormone receptors, HER2 status, etc.), and described their distribution in the studied population. By correlating IHC profiles with clinical/pathological features, the study highlighted subtype prevalence and potential prognostic or therapeutic implications.
Cervical cancer screening by molecular Pap-transformation of gynecologic cytology
This study evaluated cervical cytology samples processed through conventional smears and Liquid-Based Cytology (LBC). The findings highlight that LBC with HPV cotesting enhances diagnostic sensitivity, reduces ambiguity, and supports extended screening intervals—an important advantage in resource-limited settings. LBC combined with HPV cotesting offers more accurate detection of cervical precancerous lesions, enabling earlier intervention and reducing missed diagnoses.
An Incidental Diagnosis of Krukenberg’s Tumor (KT): Exploration beyond the Ovaries
This case report describes an incidental diagnosis of Krukenberg’s Tumor (KT) in a patient whose ovarian enlargement was not evident and whose symptoms mimicked a benign fibroid. The final diagnosis was made only via histopathology, demonstrating characteristic microscopic features. Early and accurate detection via pathology can dramatically alter management and prognosis.
Flowcytometry Immunophenotyping: Role in Acute Leukemia and Detection of Aberrant Expressions in the Indian Population
Flow-cytometry immunophenotyping is a rapid, precise tool for leukemia classification and detecting aberrant expressions. This enables rapid and accurate lineage classification, which is critical for selecting appropriate cytogenetic/molecular testing, refining prognosis, and guiding timely therapeutic decisions that directly influence patient
Malignant Mixed Germ Cell Tumour of Uterus: A Rare Case Report
Malignant mixed germ cell tumors of the uterus are exceptionally rare, with limited literature guiding diagnosis or management.The case highlights the importance of comprehensive histopathological and immunohistochemical evaluation for accurate diagnosis. Early recognition and multimodal treatment are critical, though prognosis remains guarded.
To book an Insta Home Sample Collection in 60 Minutes call us on
We’re here to assist you — reach out anytime!
About Us
Metropolis Healthcare is one of India’s leading diagnostics companies, with 45 years of experience built on scientific expertise, quality and trust. We serve millions of patients through a growing network supported by advanced laboratory infrastructure, technology and a patient-first approach. Our comprehensive portfolio includes 4,500+ tests and profiles across routine, specialised and super-specialised diagnostics, spanning pathology, molecular diagnostics, genomics, cytogenetics, oncology, neurology, nephrology, women and child health, preventive healthcare and wellness.
With 210+ clinical laboratories and a service network of 5,000+ touchpoints reaching more than 750 towns in India, we are focused on making trusted diagnostic services more accessible while maintaining rigorous quality standards. By combining scientific excellence, advanced technology and human expertise, we deliver accurate, reliable and relevant diagnostic insights that support better-informed healthcare decisions.